About Kadmon

Kadmon is a global biopharmaceutical company built on a 21st-century paradigm for the translation of innovative science into treatment. The company currently offers products and services for the treatment and management of hepatitis C. Kadmon is pioneering medicines in oncology, infectious diseases, immunology and neurodegenerative diseases by using new discoveries in molecular biology to develop therapies that target the metabolic and signaling pathways associated with disease. By challenging how treatments for serious diseases are developed today, Kadmon is developing the cures of tomorrow.

Kadmon Corporation, LLC is headquartered in New York City with operations in Warrendale, PA and Boston, MA.